Daily SPAC Update – March 3, 2025

by | Mar 3, 2025

Rigel Resource (RRAC) Deal + Aurus Deal Approved. Maywood Acquisition (MAYA) Separate Trading.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
RRAC – RIGEL RESOURCE ACQUISITION CORP * Deal Approved * 6,369,522 redeemed

SEPARATE WARRANTS/RIGHTS
Mar 07: MAYWOOD ACQUISITION CORP (MAYA)

SPAC DEALS ANNOUNCED
Feb 28 | HLXB – Helix Acquisition Corp Ii + BridgeBio Oncology Therapeutics

ABOUT BridgeBio Oncology Therapeutics
BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. Initially formed as a subsidiary of BridgeBio Pharma, Inc. (Nasdaq: BBIO), BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, visit bridgebiooncology.com.

YESTERDAY’S TOP SPAC GAINERS
2.31% ~ $ 11.05 | HLXB – HELIX ACQUISITION CORP II (Announced)
2.04% ~ $ 10.99 | ESHA – ESH ACQUISITION CORP (Pre-Deal)
.63% ~ $ 11.13 | IPXX – INFLECTION POINT ACQUISITION CORP II (Announced)
.40% ~ $ 10.16 | VACH – VOYAGER ACQUISITION CORP (Pre-Deal)
.39% ~ $ 10.17 | LPAA – LAUNCH ONE ACQUISITION CORP (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-22.37% ~ $ 6.02 | GLST – GLOBAL STAR ACQUISITION INC (Announced)
-3.90% ~ $ 3.94 | BOWN – BOWEN ACQUISITION CORP (Announced)
-2.63% ~ $ 11.10 | CCIR – COHEN CIRCLE ACQUISITION CORP I (Pre-Deal)
-1.32% ~ $ 11.25 | DMYY – DMY SQUARED TECHNOLOGY GROUP INC (Pre-Deal)
-1.23% ~ $ 12.00 | MSSA – METAL SKY STAR ACQUISITION CORP (Pre-Deal)

LATEST SPAC IPO PERFORMANCE
Feb 27 | $10.02 | NHIC – NewHold Investment Corp. III
Feb 27 | $10.02 | FERA – Fifth Era Acquisition Corp I
Feb 26 | $10.03 | RAC – Rithm Acquisition Corp.
Feb 12 | $ 10.04 | AACB – Artius II Acquisition Inc.
Feb 12 | $ 10.09 | MAYA – Maywood Acquisition Corp.
Feb 10 | $ 10.06 | ATII – Archimedes Tech SPAC Partners II Co.
Feb 06 | $ 10.02 | KFII – K GROWTH ACQUISITION CORP. II

Recent Analysis

Daily SPAC: GUAC, IDAC IPOs Add $400M in SPAC Capital – May 15, 2026

2 SPAC IPOs priced today, with Berto Acquisition Corp. II (GUAC) raising $250M and Iron Dome Acquisition I Corp (IDAC) raising $150M; IDAC funded trust at 100.5% of par. May MTD totals 9 IPOs / $1,425M through 15 days vs. 5 / $725M over the same span last month. Separately, RAAQ advanced its IQM merger with an F-4 filing.

Daily SPAC: SIMA, CAEP-Air Redemptions – May 14, 2026

SIM Acquisition I (SIMA) lost $242M from trust on its extension approval to Jul. 12, 2027, and Cantor Equity Partners III (CAEP) cleared its Air deal after $234M in redemptions. Separately, GSR V Acquisition (GSRV) priced a $200M IPO, taking May MTD to 7 SPAC IPOs / $1,025M through 14 days.

Daily SPAC: BREZ $125M IPO, GPAT Non-Redemption Agreements – May 13, 2026

GP-ACT III Acquisition (GPAT) disclosed non-redemption agreements tied to extension and trust-amendment votes, with investors pledging support and no redemptions alongside sponsor share transfers. Breeze Acquisition Corp. II (BREZ) priced a $125M IPO today with 100.2% initial trust funding; May MTD is 6 IPOs for $825M through 13 sessions vs. 2 IPOs / $350M at the same point last month.

Daily SPAC: CAEP Forward Purchase, AIR-Pubco – May 12, 2026

Cantor Equity Partners III (CAEP) announced a forward purchase with Harraden Circle to fund the CAEP-AIR-Pubco business combination. Columbus Acquisition (COLA) issued a convertible extension note to WISeSat.Space. MTD: 5 SPAC IPOs raised $700M through the first 12 sessions of May vs. 2 IPOs / $350M over the same span in April.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.